Spyros Papapetropoulos

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Increasing evidence supports a role for abnormal immune activation and inflammatory responses in Huntington disease (HD). In this study, we evaluated the therapeutic potential of laquinimod (1 and 10 mg/kg), a novel immunomodulatory agent shown to be protective in a number of neuroinflammatory conditions, in the YAC128 mouse model of HD. Treatment with(More)
  • 1